Production (Stage)
FibroBiologics, Inc.
FBLG
$0.8087
-$0.0638-7.31%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.67M | 13.99M | 7.83M | 5.97M | 8.16M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 642.00K | 225.00K | 353.00K | 518.00K | 746.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 18.00K | 18.00K | 18.00K | 18.00K | 18.00K |
| Total Current Assets | 9.33M | 14.23M | 8.20M | 6.51M | 8.92M |
|
|
|||||
| Total Current Assets | 9.33M | 14.23M | 8.20M | 6.51M | 8.92M |
| Net Property, Plant & Equipment | 2.10M | 2.22M | 2.27M | 2.40M | 2.48M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 11.43M | 16.45M | 10.47M | 8.91M | 11.40M |
|
|
|||||
| Total Accounts Payable | 1.42M | 2.70M | 1.18M | 1.21M | 814.00K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 5.84M | 9.17M | 115.00K | 287.00K | 459.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 412.00K | 401.00K | 392.00K | 382.00K | 372.00K |
| Total Finance Division Other Current Liabilities | 543.00K | 460.00K | 4.99M | 8.26M | 12.34M |
| Total Other Current Liabilities | 543.00K | 460.00K | 4.99M | 8.26M | 12.34M |
| Total Current Liabilities | 8.21M | 12.73M | 6.68M | 10.13M | 13.99M |
|
|
|||||
| Total Current Liabilities | 8.21M | 12.73M | 6.68M | 10.13M | 13.99M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 5.84M | 9.17M | 115.00K | 287.00K | 459.00K |
| Capital Leases | 865.00K | 984.00K | 1.06M | 1.17M | 1.28M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 9.08M | 13.71M | 7.73M | 11.30M | 15.26M |
|
|
|||||
| Common Stock & APIC | 42.83M | 38.25M | 35.16M | 29.53M | 28.95M |
| Retained Earnings | -40.48M | -35.52M | -32.42M | -31.92M | -32.82M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 2.35M | 2.74M | 2.74M | -2.39M | -3.86M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.35M | 2.74M | 2.74M | -2.39M | -3.86M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.35M | 2.74M | 2.74M | -2.39M | -3.86M |
|
|
|||||